SCHEDULE 14A INFORMATION

Company

Eloxx Pharmaceuticals, Inc.

Filed

October 28, 2003

Period of Report

December 15, 2003

Accession Number

0000903100-03-000366

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →